COVID-19 Vaccination Policy: The United States And China

Inrinofita Sari; Asriadi Asriadi; Achmad Nurmandi; Nurul Wahdaniyah

doi:10.31000/jgcs.v9i1.6743

COVID-19 Vaccination Policy: The United States And China

Inrinofita Sari, Asriadi Asriadi, Achmad Nurmandi, Nurul Wahdaniyah

Abstract

This study examines Covid-19 vaccination policies in the United States and China. The method used in this research is qualitative research with a literature study approach. This research sends research map information using export data to RIS Export file format, which is then processed using VOSviewers to determine the big data that will be analyzed to obtain comparative data results of this research with previous research. In the second discussion, the author processed the data using Nvivo 12 to explore and describe the COVID-19 vaccination Policy in the United States and China to explain the data efficiently. This study found that the United States and China showed a strong government response to control the spread of COVID-19. The findings suggest that countries with effective vaccination policies tend to be more successful in curbing the spread of COVID-19 than countries without vaccination programs. Governments in both countries have implemented various policies to break the chain of transmission of COVID-19, such as lockdowns, social distancing, quarantine, and vaccination policies. The vaccination policy in the United States and China is successful because the vaccination presence in the two countries is fairly high, with the United States reaching 73.65% while China reaching 87.24%.

Penelitian ini bertujuan untuk melihat kebijakan vaksinasi Covid-19 di Amerika Serikat dan China. Metode yang digunakan dalam penelitian ini adalah penelitian kualitatif dengan pendekatan studi pustaka. Penelitian ini melakukan pengiriman informasi peta penelitian dengan menggunakan data ekspor ke RIS Format file ekspor, yang kemudian diolah menggunakan VOSviewers untuk menentukan data besar yang akan dianalisis untuk memperoleh hasil data perbandingan penelitian ini dengan penelitian terdahulu. Pada pembahasan kedua, penulis mengolah data menggunakan Nvivo 12 untuk mengeksplorasi dan mendeskripsikan Kebijakan Vaksinasi Covid-19 di Amerika Serikat dan China untuk menjelaskan data secara efisien. Hasil Penelitian ini menemukan bahwa Amerika Serikat dan China menunjukkan respons pemerintah yang kuat untuk mengendalikan penyebaran COVID-19. Temuan ini menunjukkan bahwa negara dengan kebijakan vaksinasi yang efektif cenderung lebih berhasil dalam membatasi penyebaran COVID-19 dibandingkan dengan negara yang tidak memiliki program vaksinasi. Pemerintah di kedua negara telah menerapkan berbagai kebijakan untuk memutus rantai penularan COVID-19, seperti kebijakan lockdown, social distancing, karantina, dan vaksinasi. Kebijakan Vaksinasi yang ada di Amerika Serikat dan China sudah bisa dikatakan berhasil karena dengan melihat presentasi Vaksinasi di dua negara tersebut yang terbilang tinggi yaitu Amerika serikat mencapai 73,65% sedangkan China mencapai 87,24%.

Keywords

Policy, Vaccination, Covid-19, United States, China

Full Text:

PDF

References

Afolabi, A. A., & Ilesanmi, O. S. (2021). Addressing COVID-19 vaccine hesitancy: Lessons from the role of community participation in previous vaccination programs. Health Promotion Perspectives, 11(4), 434–437. https://doi.org/10.34172/hpp.2021.54

Akram, M., Nasar, A., & Arshad-Ayaz, A. (2022). A bibliometric analysis of disinformation through social media. Journal of Communication and Media Technologies, 12(4). https://doi.org/https://doi.org/10.30935/ojcmt/12545

Carson, S. L., Casillas, A., Castellon-Lopez, Y., Mansfield, L. N., Morris, D., Barron, J., Ntekume, E., Landovitz, R., Vassar, S. D., Norris, K. C., Dubinett, S. M., Garrison, N. A., & Brown, A. F. (2021). COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California. JAMA Network Open, 4(9). https://doi.org/10.1001/jamanetworkopen.2021.27582

Chen, Z., Zheng, W., Wu, Q., Chen, X., Peng, C., Tian, Y., Sun, R., Dong, J., Wang, M., Zhou, X., Zhao, Z., Zhong, G., Yan, X., Liu, N., Hao, F., Zhao, S., Zhuang, T., Yang, J., Azman, A. S., & Yu, H. (2022). Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Medicine, 20(1). https://doi.org/10.1186/s12916-022-02333-0

Chung, P.-C., & Chan, T.-C. (2021). Impact of physical distancing policy on reducing transmission of SARS-CoV-2 globally: Perspective from government’s response and residents’ compliance. PLoS One, 16(8), e0255873.

Denu, M. K. I., Montrond, A., Piltch-Loeb, R., Bonetti, M., Toffolutti, V., Testa, M. A., & Savoia, E. (2022). Freedom of Choice to Vaccinate and COVID-19 Vaccine Hesitancy in Italy. Vaccines, 10(11). https://doi.org/10.3390/vaccines10111973

Druedahl, L. C., Minssen, T., & Price, W. N. (2021). Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships. Vaccine, 39(42), 6291–6295. https://doi.org/10.1016/j.vaccine.2021.08.101

F.K. Cheng. (2022). Debate on mandatory COVID-19 vaccination. Ethics, Medicine and Public Health, 21(January), 19–21. https://doi.org/10.1016/j.jemep.2022.100761

Goel, R. K., & Nelson, M. A. (2021). Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States. NETNOMICS: Economic Research and Electronic Networking. https://doi.org/10.1007/s11066-021-09148-w

Goren, T., Beeri, I., & Vashdi, D. R. (2022). How to boost the boosters? A survey-experiment on the effectiveness of different policies aimed at enhancing acceptance of a “Seasonal” vaccination against COVID-19. Israel Journal of Health Policy Research, 11(1). https://doi.org/10.1186/s13584-022-00536-7

Hung, J. (2022). Subsets of the population benefitting from the pandemic: What policies and practices should be arranged to sustainably maintain beneficiaries’ mental health. Frontiers in Sociology, 7. https://doi.org/10.3389/fsoc.2022.1090785

Knezevic, I., Mattiuzzo, G., Page, M., Minor, P., Griffiths, E., Nuebling, M., & Moorthy, V. (2022). WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community. The Lancet Microbe, 3(3), e235–e240. https://doi.org/10.1016/S2666-5247(21)00266-4

Kusejko, K., Chammartin, F., Smith, D., Odermatt, M., Schuhmacher, J., Koller, M., Günthard, H. F., Briel, M., Bucher, H. C., Speich, B., Abela, I., Aebi-Popp, K., Anagnostopoulos, A., Battegay, M., Bernasconi, E., Braun, D. L., Calmy, A., Cavassini, M., Ciuffi, A., … Yerly, P. (2022). Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients. BMC Infectious Diseases, 22(1). https://doi.org/10.1186/s12879-022-07621-x

Liu, R., Zhang, Y., Nicholas, S., Leng, A., Maitland, E., & Wang, J. (2021). COVID-19 vaccination willingness among Chinese adults under the free vaccination policy. Vaccines, 9(3). https://doi.org/10.3390/vaccines9030292

Maltezou, H. C., Gamaletsou, M. N., Koukou, D.-M., Giannouchos, T. V, Sourri, F., Syrimi, N., Karapanou, A., Lemonakis, N., Peskelidou, E., Papanastasiou, K., Panagopoulos, P., Souliotis, K., Lourida, A., Hatzigeorgiou, D., & Sipsas, N. V. (2022). Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study. Vaccine, 40(52), 7660–7666. https://doi.org/10.1016/j.vaccine.2022.10.049

Martinho, V. J. P. D. (2021). Bibliometric analysis for working capital: Identifying gaps, co-authorships and insights from a literature survey. International Journal of Financial Studies, 9(4). https://doi.org/10.3390/ijfs9040072

Nawaz Ali, G. G. M., Rahman, M. M., Hossain, M. A., Rahman, M. S., Paul, K. C., Thill, J.-C., & Samuel, J. (2021). Public perceptions of covid-19 vaccines: Policy implications from us spatiotemporal sentiment analytics. Healthcare (Switzerland), 9(9). https://doi.org/10.3390/healthcare9091110

Ngoy, N., Oyugi, B., Ouma, P. O., Conteh, I. N., Woldetsadik, S. F., Nanyunja, M., Okeibunor, J. C., Yoti, Z., & Gueye, A. S. (2022). Coordination mechanisms for COVID-19 in the WHO Regional office for Africa. BMC Health Services Research, 22(1), 1–17. https://doi.org/10.1186/s12913-022-08035-w

Paul, K. T., Zimmermann, B. M., Corsico, P., Fiske, A., Geiger, S., Johnson, S., Kuiper, J. M. L., Lievevrouw, E., Marelli, L., Prainsack, B., Spahl, W., & Van Hoyweghen, I. (2022). Anticipating hopes, fears and expectations towards COVID-19 vaccines: A qualitative interview study in seven European countries. SSM - Qualitative Research in Health, 2. https://doi.org/10.1016/j.ssmqr.2021.100035

Rafliansah Aziz, M., Alfitras Tavares, M., & Jasmine Azhima, C. (2021). COVID-19 Vaccinations and the Right to Health in Indonesia: Social Justice Analysis. Lentera Hukum, 8(2), 211–240. https://doi.org/10.19184/ejlh.v8i2.23515

RG, G. C. (2018). A Literature-Based Review on Potentials and Constraints in the Implementation of the Sustainable Development Goals. Nucleic Acids Research, 6(1), 1–7. http://dx.doi.org/10.1016/j.gde.2016.09.008

Schmelz, K., & Bowles, S. (2021). Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out. Proceedings of the National Academy of Sciences of the United States of America, 118(25). https://doi.org/10.1073/pnas.2104912118

Setyaningsih, W., Nuryanti, W., Prayitno, B., & Sarwadi, A. (2016). Urban Heritage Towards Creative-based Tourism in the Urban Settlement of Kauman - Surakarta. Procedia - Social and Behavioral Sciences, 227, 642–649. https://doi.org/10.1016/j.sbspro.2016.06.127

Sung, M., Huang, Y., Duan, Y., Liu, F., Jin, Y., & Zheng, Z. (2021). Pharmaceutical industry’s engagement in the global equitable distribution of covid-19 vaccines: Corporate social responsibility of eul vaccine developers. Vaccines, 9(10). https://doi.org/10.3390/VACCINES9101183

Tatapudi, H., Das, R., & Das, T. K. (2021). Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States. BMC Medical Research Methodology, 21(1). https://doi.org/10.1186/s12874-021-01458-9

Vidyarthi, A., & Hyaat Khan, S. (2022). India: a late opening to the notion of international public policy? Arbitration International, 38(4), 249–261. https://doi.org/10.1093/arbint/aiac015

Wang, H., Xu, R., Qu, S., Schwartz, M., Adams, A., & Chen, X. (2021). Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health, 14(10), 1563–1565. https://doi.org/10.1016/j.jiph.2021.07.013

Wang, Q., Qu, Z., Tu, S., Chen, X., & Hou, Z. (2022). The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study. Health Research Policy and Systems, 20(1). https://doi.org/10.1186/s12961-022-00947-7

Xiao, H., & Li, L. (2021). A bibliometric analysis of critical discourse analysis and its implications. Discourse & Society. https://doi.org/10.1177/0957926521992150

Yan, K., Yan, H., & Gupta, R. (2021). The predicted trend of COVID-19 in the United States of America under the policy of “Opening Up America Again.” Infectious Disease Modelling, 6, 766–781. https://doi.org/10.1016/j.idm.2021.05.005

DOI: http://dx.doi.org/10.31000/jgcs.v9i1.6743